John Forrest retweeted
We are proud to announce that Dr Marc Pelletier (@MarcPPelletier) will be the next Chief of Cardiac Surgery @YaleCardiacSurg . @YaleMed @YaleCardiology @YaleThoracic @yalectsurgery @YaleSurgery medicine.yale.edu/surgery/ne…
A privilege to play a small role in advancing care for our Veterans.
It’s official!! VA CT is now a part of the TAVR family!! Amazing Cath lab & OR team collaboration. We are now the first and only VA Cath Lab in the nation to offer TAVR in a non-operating room setting✨Huge step forward for improving care for our Veterans!🙌🏻 @TAVR @Edwardslifesci @johnkforrest @Pfausteve @Samitshahmd, @RolandAssiMD, Michael Cleman MD, J. Cleman MD, @faridjad, @yalecardiology
There's a new version of this post
John Forrest retweeted
A recent study compares two approaches to treating severe aortic stenosis & the effectiveness & safety of treatments for patients.
The study offers a detailed analysis & limitations of each approach. Read more from Dr. @johnkforrest of @YaleCardiology.
medicine.yale.edu/intmed/new…
John Forrest retweeted
#TCT2023 #JACC LBCT SimPub: There was a 26% relative reduction (P = 0.05) in hazard for all-cause mortality or disabling #stroke with #TAVR vs #SAVR, and the difference expanded over time.
Learn more: bit.ly/406JIZZ
#CardioTwitter #EVOLUT @johnkforrest
John Forrest retweeted
In the latest episode of @HFSA's Heart Failure Beat podcast, @MHBeasleyMD & @priyaumapathi discussed coronary revascularization in patients with ischemic heart failure with Dr. Yousif Ahmad.
Ahmad shares best practices & more.
@YaleCardiology @YaleHF
medicine.yale.edu/intmed/new…
John Forrest retweeted
The rate of deaths and disabling strokes among patients who were treated with transcatheter aortic valve replacement or #TAVR remained low at 3 years.
Learn about the #Evolut low risk study with John K. Forrest MD, on ACC Anywhere: rb.gy/dyr6m
@YaleMed @YaleIMed
John Forrest retweeted
.@YNHH Heart & Vascular Center recently performed the 1st transcatheter left ventricular restoration procedure in New England. This procedure, designed to treat patients w/ congestive heart failure, was performed as part of a clinical trial. ynh.care/6012OZg6C
John Forrest retweeted
Watch the newest #ACCessPoints video for practice-changing highlights from the EVOLUT LOW RISK trial presented at #ACC23/#WCCardio with @CMichaelGibson & @johnkforrest.
John Forrest retweeted
#ACC23/#WCCardio #JACC LBCT SimPub: Data from the Evolut Low Risk trial demonstrated that #TAVR at 3 years showed durable benefits compared with surgery with respect to all-cause mortality or disabling stroke. bit.ly/3kT770B
#vhdAS #SAVR #CardioTwitter @kashishgoelmd
John Forrest retweeted
It’s an All Bulldog Final. Come on down to Northford tomorrow night!!! #BowWow
John Forrest retweeted
John N. Forrest Jr., MD, professor of medicine (nephrology) and former director, Office of Student Research, will retire from Yale School of Medicine, effective July 1, 2020. medicine.yale.edu/intmed/new…















